Kestra Private Wealth Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $862K | Buy |
6,812
+278
| +4% | +$35.2K | 0.01% | 796 |
|
|
2025
Q1 | $836K | Buy |
6,534
+169
| +3% | +$21.6K | 0.01% | 748 |
|
|
2024
Q4 | $842K | Buy |
6,365
+1,284
| +25% | +$170K | 0.01% | 704 |
|
|
2024
Q3 | $740K | Buy |
5,081
+552
| +12% | +$80.4K | 0.01% | 722 |
|
|
2024
Q2 | $622K | Sell |
4,529
-461
| -9% | -$63.3K | 0.01% | 744 |
|
|
2024
Q1 | $685K | Sell |
4,990
-451
| -8% | -$61.9K | 0.02% | 684 |
|
|
2023
Q4 | $739K | Sell |
5,441
-1,372
| -20% | -$186K | 0.02% | 608 |
|
|
2023
Q3 | $833K | Sell |
6,813
-1,373
| -17% | -$168K | 0.03% | 515 |
|
|
2023
Q2 | $1.04M | Sell |
8,186
-60
| -0.7% | -$7.62K | 0.04% | 421 |
|
|
2023
Q1 | $1.07M | Buy |
8,246
+208
| +3% | +$26.9K | 0.04% | 395 |
|
|
2022
Q4 | $1.06M | Buy |
8,038
+2,166
| +37% | +$284K | 0.05% | 360 |
|
|
2022
Q3 | $687K | Buy |
5,872
+134
| +2% | +$15.7K | 0.04% | 413 |
|
|
2022
Q2 | $675K | Sell |
5,738
-557
| -9% | -$65.5K | 0.04% | 419 |
|
|
2022
Q1 | $820K | Buy |
6,295
+279
| +5% | +$36.3K | 0.04% | 427 |
|
|
2021
Q4 | $918K | Sell |
6,016
-911
| -13% | -$139K | 0.04% | 406 |
|
|
2021
Q3 | $1.12M | Buy |
6,927
+920
| +15% | +$149K | 0.06% | 326 |
|
|
2021
Q2 | $983K | Buy |
6,007
+913
| +18% | +$149K | 0.06% | 332 |
|
|
2021
Q1 | $767K | Sell |
5,094
-770
| -13% | -$116K | 0.05% | 356 |
|
|
2020
Q4 | $894K | Sell |
5,864
-408
| -7% | -$62.2K | 0.07% | 299 |
|
|
2020
Q3 | $849K | Buy |
+6,272
| New | +$849K | 0.07% | 269 |
|